| Rising proportion of young individuals with rectal and colon cancer PM Kasi, F Shahjehan, JJ Cochuyt, Z Li, DT Colibaseanu, A Merchea Clinical colorectal cancer 18 (1), e87-e95, 2019 | 143 | 2019 |
| Body mass index and long-term outcomes in patients with colorectal cancer F Shahjehan, A Merchea, JJ Cochuyt, Z Li, DT Colibaseanu, PM Kasi Frontiers in Oncology 8, 620, 2018 | 61 | 2018 |
| Impact of tumor location and variables associated with overall survival in patients with colorectal cancer: a mayo clinic colon and rectal cancer registry study CB Wang, F Shahjehan, A Merchea, Z Li, TS Bekaii-Saab, A Grothey, ... Frontiers in oncology 9, 76, 2019 | 56 | 2019 |
| Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma B Yarlagadda, V Kamatham, A Ritter, F Shahjehan, PM Kasi NPJ precision oncology 3 (1), 19, 2019 | 39 | 2019 |
| Trends and outcomes of sphincter-preserving surgery for rectal cancer: a national cancer database study F Shahjehan, PM Kasi, E Habermann, CN Day, DT Colibaseanu, ... International Journal of Colorectal Disease 34, 239-245, 2019 | 23 | 2019 |
| Colorectal cancer characteristics and outcomes after solid organ transplantation A Merchea, F Shahjehan, KP Croome, JJ Cochuyt, Z Li, DT Colibaseanu, ... Journal of oncology 2019, 2019 | 22 | 2019 |
| Immune checkpoint inhibitors in metastatic colorectal cancer: current status, recent advances, and future directions S Kamatham, F Shahjehan, PM Kasi Current Colorectal Cancer Reports 15, 112-121, 2019 | 19 | 2019 |
| Feasibility of integrating panel-based pharmacogenomics testing for chemotherapy and supportive care in patients with colorectal cancer PM Kasi, T Koep, E Schnettler, F Shahjehan, V Kamatham, C Baldeo, ... Technology in Cancer Research & Treatment 18, 1533033819873924, 2019 | 15 | 2019 |
| Role of circulating tumor dna in gastrointestinal cancers: update from abstracts and sessions at ASCO 2018 F Shahjehan, S Kamatham, PM Kasi Frontiers in Oncology 9, 358, 2019 | 15 | 2019 |
| Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancer. F Shahjehan, S Kamatham, C Chandrasekharan, PM Kasi Drugs of today (Barcelona, Spain: 1998) 55 (11), 683-693, 2019 | 14 | 2019 |
| BRAF-V600E and microsatellite instability prediction through CA-19-9/CEA ratio in patients with colorectal cancer PM Kasi, S Kamatham, F Shahjehan, Z Li, PW Johnson, A Merchea, ... Journal of Gastrointestinal Oncology 11 (2), 236, 2020 | 9 | 2020 |
| A Care Process Model to Deliver 177Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors PM Kasi, CL Maige, F Shahjehan, JM Rodgers, DL Aloszka, A Ritter, ... Frontiers in oncology 8, 663, 2019 | 7 | 2019 |
| Circulating tumor DNA-based detection of microsatellite instability and response to immunotherapy in pancreatic cancer S Kamatham, F Shahjehan, PM Kasi Frontiers in Pharmacology 11, 504078, 2020 | 6 | 2020 |
| Impact of tumor location and variables associated with overall survival in patients with colorectal cancer. CB Wang, A Merchea, F Shahjehan, D Colibaseanu, J Cochuyt, Z Li, ... Journal of Clinical Oncology 36 (15_suppl), e15651-e15651, 2018 | 4 | 2018 |
| Dramatic response to modified docetaxel, cisplatin, and fluorouracil chemotherapy after immunotherapy in a patient with refractory metastatic anal cancer F Shahjehan, S Kamatham, A Ritter, PM Kasi Clinical Case Reports 7 (9), 1729-1734, 2019 | 2 | 2019 |
| Characteristics and outcomes of patients with colorectal cancer and bone metastasis. F Shahjehan, S Kamatham, J Cochuyt, Z Li, D Colibaseanu, A Merchea, ... Journal of Clinical Oncology 37 (15_suppl), e15063-e15063, 2019 | 2 | 2019 |
| Body mass index and long-term outcomes in patients with colorectal cancer. D Colibaseanu, F Shahjehan, J Cochuyt, Z Li, A Merchea, PM Kasi Journal of Clinical Oncology 36 (15_suppl), e15631-e15631, 2018 | 2 | 2018 |
| Liquid biopsy concordance based on clonality and timing of testing in patients with metastatic colorectal cancer PM Kasi, S Kamatham, F Shahjehan, Z Li, PW Johnson, A Merchea, ... Annals of Oncology 30, v235, 2019 | 1 | 2019 |
| Metastatic anal cancer S Kamatham, F Shahjehan, PM Kasi Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and …, 2019 | 1 | 2019 |
| BRAF-V600E and microsatellite instability prediction through CA-19-9/CEA ratio in patients with colorectal cancer. PM Kasi, S Kamatham, D Colibaseanu, F Shahjehan, A Merchea Journal of Clinical Oncology 37 (15_suppl), e15065-e15065, 2019 | 1 | 2019 |
Pashtoon Murtaza Kasi, MD, MSWeill Cornell MedicineVerified email at med.cornell.edu
Pashtoon Murtaza Kasi, MD, MSWeill Cornell MedicineVerified email at med.cornell.edu